Pay in 4 interest-free payments of $5.48 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
GHK-Cu is the tripeptide glycyl-L-histidyl-L-lysine bound to a copper(II) ion
FASN Inhibition as a potential treatment for endocrine-resistant breast cancer
doi: 10.2527/af.2014-0014 91
Key takeaways GLP-1 drugs, such as Ozempic and Wegovy, are increasingly popular for their role in weight loss and managing Type 2 diabetes through appetite regulation and blood sugar level control
Bayesian approaches were featured for their enhanced detection of ADRs
September 26 Product: AstraZenecas Tagrisso Indication : Non-small cell lung cancer AstraZeneca expanded the reach of its non-small cell lung cancer (NSCLC) drug Tagrisso Thursday as the FDA greenlit the treatment for adults with unresectable, Stage III epidermal growth factor receptor-mutated (EGFRm) disease that has not progressed during or following concurrent or sequential platinum-based chemoradiation therapy
US$ 28.06
US$ 27.10
US$ 23.53
US$ 20.22
US$ 21.57
US$ 27.92
US$ 20.84
US$ 27.89
